Recall Enforment Report D-0432-2023
Drug Recall Enforcement Report Class II voluntary initiated by The Harvard Drug Group, originally initiated on 02-23-2023 for the product Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, Packaged and Distributed by: Major Pharmaceuticals Indianapolis, IN 46268 USA. NDC 0904-7257-61, UPC 3 09047 25761 4 The product was recalled due to packaging defect: observed packaging defect, blister packaging inadequately sealed.. The product was distributed nationwide and the recall is currently ongoing.
|NDC||Proprietary Name||Non-Proprietary Name||Dosage Form||Route Name||Company Name||Product Type|
|0904-7257||Carbidopa And Levodopa||Carbidopa And Levodopa||Tablet||Oral||Major Pharmaceuticals||Human Prescription Drug|